Mark Schreuder

1.1k total citations
10 papers, 488 citations indexed

About

Mark Schreuder is a scholar working on Hematology, Internal Medicine and Genetics. According to data from OpenAlex, Mark Schreuder has authored 10 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Internal Medicine and 3 papers in Genetics. Recurrent topics in Mark Schreuder's work include Blood Coagulation and Thrombosis Mechanisms (5 papers), Venomous Animal Envenomation and Studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mark Schreuder is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (5 papers), Venomous Animal Envenomation and Studies (3 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Mark Schreuder collaborates with scholars based in Netherlands, Australia and France. Mark Schreuder's co-authors include Andrew J. Hoy, Lisa S. Lee, Seher Balaban, Michelle van Geldermalsen, Rose Cairns, Darren N. Saunders, Thomas Grewal, Robert F. Shearer, Daniel J. Fazakerley and Kristen C. Thomas and has published in prestigious journals such as Blood, Thrombosis and Haemostasis and Journal of Thrombosis and Haemostasis.

In The Last Decade

Mark Schreuder

10 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Schreuder Netherlands	7	273	236	96	82	66	10	488
David O. Osei-Hwedieh United States	8	163 0.6×	231 1.0×	28 0.3×	105 1.3×	25 0.4×	16	495
Frédérique Fallone France	10	223 0.8×	316 1.3×	185 1.9×	77 0.9×	68 1.0×	12	574
Fariborz Rashid-Kolvear Canada	9	60 0.2×	254 1.1×	67 0.7×	86 1.0×	71 1.1×	19	471
Lahoucine Izem United States	12	114 0.4×	217 0.9×	50 0.5×	33 0.4×	31 0.5×	22	425
Ravi Jahagirdar United States	10	87 0.3×	440 1.9×	79 0.8×	57 0.7×	48 0.7×	22	687
Shuijie Li China	13	139 0.5×	248 1.1×	96 1.0×	29 0.4×	55 0.8×	31	466
Bernard Ayanga United States	7	237 0.9×	444 1.9×	50 0.5×	63 0.8×	55 0.8×	7	589
Inês Cebola United Kingdom	10	96 0.4×	379 1.6×	68 0.7×	21 0.3×	43 0.7×	22	674
Bart Lammers Netherlands	10	104 0.4×	187 0.8×	108 1.1×	42 0.5×	69 1.0×	15	473
Johnny Yu United States	6	109 0.4×	205 0.9×	100 1.0×	15 0.2×	13 0.2×	9	337

Countries citing papers authored by Mark Schreuder

Since Specialization

Citations

This map shows the geographic impact of Mark Schreuder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Schreuder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Schreuder more than expected).

Fields of papers citing papers by Mark Schreuder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Schreuder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Schreuder. The network helps show where Mark Schreuder may publish in the future.

Co-authorship network of co-authors of Mark Schreuder

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Schreuder. A scholar is included among the top collaborators of Mark Schreuder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Schreuder. Mark Schreuder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Schreuder, Mark, Georges Jourdi, David A. Poole, et al.. (2024). Minimally modified human blood coagulation factor X to bypass direct factor Xa inhibitors. Journal of Thrombosis and Haemostasis. 22(8). 2211–2226. 1 indexed citations

Shon, Ivan Ho, et al.. (2021). Preclinical Assessment of [68Ga]Ga-Cell Death Indicator (CDI): A Novelhsp90 Ligand for Positron Emission Tomography of Cell Death. Current Radiopharmaceuticals. 15(3). 184–193. 4 indexed citations

Schreuder, Mark, Pieter H. Reitsma, & Mettine H.A. Bos. (2020). Reversal Agents for the Direct Factor Xa Inhibitors: Biochemical Mechanisms of Current and Newly Emerging Therapies. Seminars in Thrombosis and Hemostasis. 46(8). 986–998. 10 indexed citations

Schreuder, Mark, et al.. (2020). Evolutionary Adaptations in Pseudonaja Textilis Venom Factor X Induce Zymogen Activity and Resistance to the Intrinsic Tenase Complex. Thrombosis and Haemostasis. 120(11). 1512–1523. 6 indexed citations

Schreuder, Mark, Pieter H. Reitsma, & Mettine H.A. Bos. (2019). Blood coagulation factor Va's key interactive residues and regions for prothrombinase assembly and prothrombin binding. Journal of Thrombosis and Haemostasis. 17(8). 1229–1239. 38 indexed citations

Schreuder, Mark, et al.. (2018). Elevated coagulation factor levels affect the tissue factor-threshold in thrombin generation. Thrombosis Research. 172. 104–109. 13 indexed citations

Balaban, Seher, Robert F. Shearer, Lisa S. Lee, et al.. (2017). Adipocyte lipolysis links obesity to breast cancer growth: adipocyte-derived fatty acids drive breast cancer cell proliferation and migration. Cancer & Metabolism. 5(1). 1–1. 329 indexed citations

Balaban, Seher, Lisa S. Lee, Mark Schreuder, & Andrew J. Hoy. (2015). Obesity and Cancer Progression: Is There a Role of Fatty Acid Metabolism?. BioMed Research International. 2015. 1–17. 78 indexed citations

Schreuder, Mark, et al.. (2015). Engineered Factor Xa Variants Retain Procoagulant Activity Independent of Direct Factor Xa-Inhibitors. Blood. 126(23). 126–126. 7 indexed citations

10.

Wang, Qian, Rae‐Anne Hardie, Andrew J. Hoy, et al.. (2015). Inhibition of ASCT2-mediated glutamine uptake blocks prostate cancer growth. QUT ePrints (Queensland University of Technology). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact